US · guidance
CMS Pub. 100-03, ch. 1, § 220.6.19
Positron Emission Tomography NaF-18 (NaF-18 PET) to Identify Bone
Metastasis of Cancer (Effective February 26, 2010)
(Rev. 11158, Issued: 12-16-21, Effective:12-15-2017, Implementation: 01-27-22)
A. General
Positron Emission Tomography (PET) is a minimally-invasive, diagnostic imaging procedure that
assesses the level of metabolic activity and perfusion in various organ systems of the body. A positron
camera (tomograph) is used to produce cross-sectional tomographic images, which are obtained from
positron-emitting radioactive tracer substances (radiopharmaceuticals) such as F-18 sodium fluoride
(NaF-18).
B. Nationally Covered Indications
The confirmatory analyses were not published during the 24-month time period. Therefore, effective
December 15, 2017, CMS determines that there are no nationally covered indications for PET NaF-18.
C. Nationally Non-Covered Indications
Effective December 15, 2017, CMS determines that PET NaF-18 PET is nationally non-covered.
D. Other
Other PET radiopharmaceutical tracers for cancer can be covered at local Medicare Administrative
Contractor discretion when used according to their FDA-approved indication(s).
(This NCD last reviewed December 2017.)
History
(Rev. 11158, Issued: 12-16-21, Effective:12-15-2017, Implementation: 01-27-22)
Provenance
- Source
- cms.gov
- Retrieved
- 2026-08-25
- Edition
- iom-2026-08-25
- Content hash
3f6820232cd3a9fdee58316d49bab2563ee5055a29c3d0b8632eb8a4dd073168
The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.
Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.